GlassScriptPhysician profile
Brandy M Hughes
NPI 1497972665
$2,061.52
in general payments reported to CMS, 2019-2025
27 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $71.15 · 2021: $312 · 2022: $432 · 2023: $599 · 2024: $236 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $560.20 | 2019-2025 | |
| Hologic Sales and Service, LLC | $457.48 | 2019-2025 | Acessa Provu System, Coolseal Generator, Fluent Fluid Management System |
| Sumitomo Pharma America, INC. | $137.90 | 2023-2024 | Myfembree |
| Agile Therapeutics, INC. | $110.69 | 2021-2022 | |
| Coopersurgical, INC. | $91.31 | 2022-2025 | Paragard T 380a, Paragard T 380a, Endosee |
| Myovant Sciences INC. | $73.34 | 2021-2022 | |
| Exeltis, USA INC. | $64.78 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $62.92 | 2021-2025 | |
| Organon LLC | $56.25 | 2025 | Nexplanon |
| Avion Pharmaceuticals | $52.34 | 2021-2022 | |
| Astellas Pharma US INC | $47.39 | 2019 | |
| Merck Sharp & Dohme LLC | $35.64 | 2024-2025 | Gardasil 9, Gardasil |
| Axonics, INC. | $31.14 | 2022-2023 | Bulkamid, Axonics |
| Novo Nordisk INC | $28.48 | 2019-2023 | Wegovy |
| Therapeuticsmd, INC. | $27.65 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $27.05 | 2022 | |
| Amag Pharmaceuticals, INC. | $25.82 | 2019 | |
| Vertical Pharmaceuticals, LLC | $25.58 | 2019 | |
| Duchesnay USA Incorporated | $24.50 | 2019 | |
| Exact Sciences Corporation | $19.71 | 2024 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $18.15 | 2025 | |
| Becton, Dickinson and Company | $17.15 | 2023 | Bd Onclarity |
| Minerva Surgical, INC | $15.60 | 2023 | |
| Pfizer INC. | $15.23 | 2022 | |
| Boston Scientific Corporation | $12.13 | 2019 | |
| Lupin INC. | $11.82 | 2020 | |
| Mylan Pharmaceuticals INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.